Bernd is PrimeForce Consultant at Novartis pharmaceutical development, focussing on radioligand theragnostic development. Recently he pursued interests in long-acting injectables, patient-centric product design and competitive intelligence. Before retirement he was technical project leader for several parenteral and topical drug products. He led also the innovation strategy for NCE pharmaceutical development. Externally Dr. Riebesehl has been serving the Focus Group Drug Delivery of the International Association for Pharmaceutical Technology (APV). He completed his thesis in Pharmaceutical Technology at the Technical University of Braunschweig. 1992 he had started his industrial career at Lilly Forschung GmbH in Hamburg leading several teams for preformulation, early phase development and several initiatives enabling the formulation of poorly soluble drugs. In 2007 he became Director of Pharmaceutical Development at Speedel Experimenta AG, Basel.